| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |